Investigating clinical associations between genomic alterations and prostate cancer lineage states using circulating tumor cell RNA sequencing. This is an ASCO Meeting Abstract from the 2025 ASCO ...

In March 2025, Akeso initiated an open-label, Phase Ib/II study involving patients diagnosed with acute myeloid leukemia (AML ...

Anti-P-selectin antibody Adakveo became the first new treatment for VOCs in SCD patients in decades when it was approved for marketing in the EU, a few months after the FDA gave it the nod in the ...